Opioid dependence in anesthesiologists creates an economic cost driven by professional vacancy rather than drug consumption.
April 24, 2026
Original Paper
Fentanyl Dependence in Anesthesiology: A Cycle-Based Analysis of Pharmacological Consumption, Occupational Loss, and System-Level Economic Burden
SSRN · 6529818
The Takeaway
Economic losses from opioid dependence in the medical field are driven by the cycle of removing and reintegrating highly skilled professionals. Standard models focus on the cost of the drugs or the immediate healthcare expenses of the addict. This research shows that the real systemic burden comes from the loss of an operator who took decades to train. Each time a specialist is pulled from the operating room, the ripple effect on hospital efficiency and surgical throughput creates massive hidden costs. Addressing addiction in medicine requires a focus on professional retention and rehabilitation rather than just pharmacological treatment.
From the abstract
Economic analyses of opioid use disorder treat pharmacological consumption as the primary cost driver. In anesthesiology, that framing is structurally wrong. The drug expenditure is not where the damage concentrates-operator removal is, and what makes it economically catastrophic is not the single event but the cycle: each reintegration restores access, and the system reproduces the same loss configuration from the beginning. The central result is structural. Under a baseline of eight to twelve